Pa Treatment & Healing Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 28 N Front St, Milton, PA 17847 Phone: 570-246-5866 Fax: 570-246-5888 |
Diversified Treatment Alternative Centers Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 40 Lawton Ln, Milton, PA 17847 Phone: 570-524-9986 |
Diversified Treatment Alternative Centers, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 40 Lawton Ln, Milton, PA 17847 Phone: 570-524-0307 |
Diversified Treatment Alternative Centers Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 40 Lawton Ln, Milton, PA 17847 Phone: 732-710-4431 |
Diversified Treatment Alternative Centers Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 40 Lawton Ln, Milton, PA 17847 Phone: 570-524-0307 |
News Archive
The formal European Launch of Lab Tests Online, the peer reviewed, patient-centred, non-commercial source of information on laboratory testing, will take place on Thursday, 31 January at La Bibliotheque Solvay in Brussels.
Lorus Therapeutics Inc. today announced the start of a development program aimed at expanding the therapeutic application of its lead clinical-stage drug LOR-2040 for the treatment of superficial bladder cancer.
According to a new study from a team of nurses headed by Melly Turner, R.N., systolic blood pressure can be an average of 14 points higher when taken immediately after arriving in the exam room and sitting on an examination table rather than sitting in a chair with your back supported and feet flat on the floor. In fact, all study participants had lower systolic and diastolic blood pressure measurements when seated in a chair versus the exam table.
Noninvasive contrast-enhanced ultrasound imaging, combined with proteomic analyses of blood samples may help physicians identify early-stage ovarian cancer and save the lives of many women, according to an article published in the February issue of the American Journal of Roentgenology.
TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for its newest product, the Gliderâ„¢ balloon catheter, for percutaneous transluminal angioplasty (PTA) of lesions in the peripheral vasculature including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries.
› Verified 2 days ago